Excited to announce this🔥letter to the editor by Carl G Streed Jr MD MPH FACP FAHA (he/him) and me just published in #JAMA JAMA regarding #gender eligibility descriptions for clinical trials! ⚠️ #Burton et al reported nearly two-thirds of trials reported applying gender-based eligibility using sex

Sudha Kodali Dr Kodali our Houston Methodist MD expert in liver cancer! I am amazed how much she and this program pushed for Tx for #cholangiocarcinoma ! #LiverTwitter Nicole Rich Amit Singal Ju Dong Yang

HE & DES are such confusing diagnoses! Anh Nguyen, MD shows that while many patients have spontaneous resolution, a smaller few could evolve to achalasia 🤷‍♀️ This is why I tend to treat conservatively at first, though some data on #POEM success also exists. #oeso2024

Professor Anjana PIllai presenting the North American policy for HCC at ILTS . 10,000 liver transplants in USA in 2023!! A record was broken. ILTS Anjana Pillai AASLD

Now published in CGH : American Gastroenterological Association (AGA) Clinical Practice Update on Management of #IBD in Patients with #Malignancy authors.elsevier.com/c/1j5Hd5UiFSkl… Immense thanks to Jana G Hashash, MD, MSc and #StevenItzkowitz for helping to pull this together!

So lucky to have Tiffany Wu, MD presenting at UTSW Gastroenterology Fellowship Grand Rounds on #Digital Opportunities for Care in Alcohol-associated Liver Disease❕ #AUD #LiverTwitter #DigitalHealth

First FDA-Approved NASH Treatment Produces NASH Resolution & Decreases Fibrosis: Results From the Landmark Phase 3 MAESTRO-NASH Trial Reviewers: Dr. Phillip Leff & Dr. Nicole Rich 📖gi.org/journals-publi… 🔊webfiles.gi.org/podcasts/ebgi/… Evidence-Based GI Doc Nicole Rich

Thank you @phillyinquirer for sharing our Annals of Int Med paper! Race is a great variable to study the effects of systemic racism & explore social differences, but is a bad variable for clinical decision-making. Unfortunately it's pervasive in algorithms👇🏽 inquirer.com/health/racial-…

Keynote Health Equity Lecture ABGH #ABGH Summit by Fola May, MD PhD ❕ “Evolving Epidemiology Of Early Onset Colorectal Cancer And Disparities”

TOMORROW 12:30 PM at 146AB - Amit Patel, MD, AGAF, FACG presenting at Digestive Disease Week American Gastroenterological Association (AGA) Postgraduate Course on Esophageal Manometry and EndoFLIP Christen Dilly Laura Raffals, MD The American Foregut Society ANMS

A moving speech by Fasiha Kanwal on the American Gastroenterological Association (AGA) Distinguished Clinician Scientist award for Hashem el- Serag - from Gaza City to AGA President & Baylor DOM Chair. Truly a remarkable career 👏🏽

Rock 🌟 Russell Rosenblatt absolutely crushed 🙌 at #DDW2024 addressing disparities in liver disease and how to act!!! - need to CARE (collaborate, advocacy, research, education)!!! - the time is now and need to involve other medical specialties, PCPS and patients -amazing 🔥 talk

Such an honor to speak /moderate the Tri-Society sponsored Symposium on #MASLD! Bariatric surgery and endobariatrics are very safe and effective #weghtloss Tx but need more data on liver outcomes for both! American Gastroenterological Association (AGA) ASGE GI Endoscopy AASLD Foundation AASLD Nicole Rich

We mourn the loss of Dr. Aslan Turer, a dear colleague and friend, and we send our sincere condolences to all who knew and loved him. Read our tribute here: tinyurl.com/55zdcbfs UT Southwestern Medical Center Thomas Wang, MD

Who wants to shop w/ me and for a great cause?? #ASCO24 is almost here which means it’s time to support Conquer Cancer, the ASCO Foundation - see you Friday 5/31 from 4-6pm and have a glass of bubbly with us while you shop Max Mara! Or shop anytime during the weekend! ASCO Lori Pierce Stephanie Graff, MD, FACP, FASCO

Join me, Joel Rubenstein, Sachin Wani and Swathi Eluri MD MSCR on June 11 noon EDT to learn about the new American Gastroenterological Association (AGA) guidelines on endoscopic management of Barrett's Esophagus #GastroBites 🔸Treatment vs no treatment for LGD 🔸EMR vs ESD for visible esophageal lesion 🔥

Congratulations Nancy Reau Janice and Jenn! #womeninliver #womeningi #livertwitter

🔥news from #EASL2024 Outcome of pts with HCC who achieved a complete response to ICI-based therapy 👉🗺️RWD, 174/3933 pts 👉mRFS 30 mo, 3yr OS 87% 😅Great to report recurrence free survival (!) after systemic therapy in advanced HCC ESMO - Eur. Oncology EASL Education ILCA #livertwitter

🔥news from #EASL2024 Liver transplantation following HCC downstaging with atezolizumab/bevacizumab: preliminary results of the ImmunoXXL study 👏still early, but amazing data 👉ICI before LTx seems feasible & safe 🧐Real chance to improve outcome in HCC EASL Education ESMO - Eur. Oncology

Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC Journal of Hepatology doi.org/10.1016/j.jhep… 🔎systematic review, 91 pts 👉26.4% rejections & 9.9% deaths 👉washout length⬆️ > allograft rejection risk⬇️ 🧐Important data to optimize outcome